Evidence map›Paper›PMID 26097677›Full record

ArticleCell & bioscience2015

Metabolomic profiling of Burkholderia pseudomallei using UHPLC-ESI-Q-TOF-MS reveals specific biomarkers including 4-methyl-5-thiazoleethanol and unique thiamine degradation pathway.

Susanna K P Lau, Ching-Wan Lam, Shirly O T Curreem, Kim-Chung Lee, Wang-Ngai Chow, Candy C Y Lau, Siddharth Sridhar, Sally C Y Wong, Paolo Martelli, Suk-Wai Hui and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell & bioscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Discovery of functional compounds from dimorphic edibleSynthetic and systems biotechnology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Influence ofMetabolites · 2024
    Article
  6. Article
  7. Article
  8. Melioidosis in Hong Kong.Tropical medicine and infectious disease · 2018
    Review
  9. Clinical Mass Spectrometry in the Bioinformatics Era: A Hitchhiker's Guide.Computational and structural biotechnology journal · 2018
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Susanna K P LauState Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Room 423, University Pathology Building, Queen Mary Hospital, Pok Fu Lam, Hong Kong ; Research Centre of Infection and Immunology, The University of Hong Kong, Pok Fu Lam, Hong Kong ; Carol Yu Centre for Infection, The University of Hong Kong, Pok Fu Lam, Hong Kong ; Department of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Ching-Wan LamDepartment of Pathology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Shirly O T CurreemDepartment of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Kim-Chung LeeDepartment of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Wang-Ngai ChowDepartment of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Candy C Y LauDepartment of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Siddharth SridharDepartment of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Sally C Y WongDepartment of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Paolo MartelliOcean Park Corporation, Aqua City, Hong Kong.
Suk-Wai HuiOcean Park Corporation, Aqua City, Hong Kong.
Kwok-Yung YuenState Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Room 423, University Pathology Building, Queen Mary Hospital, Pok Fu Lam, Hong Kong ; Research Centre of Infection and Immunology, The University of Hong Kong, Pok Fu Lam, Hong Kong ; Carol Yu Centre for Infection, The University of Hong Kong, Pok Fu Lam, Hong Kong ; Department of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Patrick C Y WooState Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, The University of Hong Kong, Room 423, University Pathology Building, Queen Mary Hospital, Pok Fu Lam, Hong Kong ; Research Centre of Infection and Immunology, The University of Hong Kong, Pok Fu Lam, Hong Kong ; Carol Yu Centre for Infection, The University of Hong Kong, Pok Fu Lam, Hong Kong ; Department of Microbiology, The University of Hong Kong, Pok Fu Lam, Hong Kong.
University of Hong Kong · HKOcean Park Conservation Foundation · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBurkholderia pseudomallei is an emerging pathogen that causes melioidosis, a serious and potentially fatal disease which requires prolonged antibiotics to prevent relapse. However, diagnosis of melioidosis can be difficult, especially in culture-negative cases. While metabolomics represents an uprising tool for studying infectious diseases, there were no reports on its applications to B. pseudomallei. To search for potential specific biomarkers, we compared the metabolomics profiles of culture supernatants of B. pseudomallei (15 strains), B. thailandensis (3 strains), B. cepacia complex (14 strains), P. aeruginosa (4 strains) and E. coli (3 strains), using ultra-high performance liquid chromatography-electrospray ionization-quadruple time-of-flight mass spectrometry (UHPLC-ESI-Q-TOF-MS). Multi- and univariate analyses were used to identify specific metabolites in B. pseudomallei.

resultsPrincipal component and partial-least squares discrimination analysis readily distinguished the metabolomes between B. pseudomallei and other bacterial species. Using multi-variate and univariate analysis, eight metabolites with significantly higher levels in B. pseudomallei were identified. Three of the eight metabolites were identified by MS/MS, while five metabolites were unidentified against database matching, suggesting that they may be potentially novel compounds. One metabolite, m/z 144.048, was identified as 4-methyl-5-thiazoleethanol, a degradation product of thiamine (vitamin B1), with molecular formula C6H9NOS by database searches and confirmed by MS/MS using commercially available authentic chemical standard. Two metabolites, m/z 512.282 and m/z 542.2921, were identified as tetrapeptides, Ile-His-Lys-Asp with molecular formula C22H37N7O7 and Pro-Arg-Arg-Asn with molecular formula C21H39N11O6, respectively. To investigate the high levels of 4-methyl-5-thiazoleethanol in B. pseudomallei, we compared the thiamine degradation pathways encoded in genomes of B. pseudomallei and B. thailandensis. While both B. pseudomallei and B. thailandensis possess thiaminase I which catalyzes degradation of thiamine to 4-methyl-5-thiazoleethanol, thiM, which encodes hydroxyethylthiazole kinase responsible for degradation of 4-methyl-5-thiazoleethanol, is present and expressed in B. thailandensis as detected by PCR/RT-PCR, but absent or not expressed in all B. pseudomallei strains. This suggests that the high 4-methyl-5-thiazoleethanol level in B. pseudomallei is likely due to the absence of hydroxyethylthiazole kinase and hence reduced downstream degradation.

conclusionEight novel biomarkers, including 4-methyl-5-thiazoleethanol and two tetrapeptides, were identified in the culture supernatant of B. pseudomallei.

Indexed as

BiomarkersBurkholderia pseudomalleiMetabolomicsSpecific

Identifiers

PMID26097677
PMCPMC4475313
OpenAlexW1544937424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.